Donald Rodrick
About Donald Rodrick
Donald Rodrick is a Sr. Manager at Bristol Myers Squibb in Warren, NJ, with extensive experience in quality oversight and analytical method development in the pharmaceutical industry.
Company
Donald Rodrick is currently employed at Bristol Myers Squibb, a prominent global biopharmaceutical company. He has been with the company since February 2019 and is based in Warren, NJ. Bristol Myers Squibb is known for its focus on discovering, developing, and delivering innovative medicines that help patients suffering from serious diseases.
Title
Donald Rodrick holds the position of Senior Manager at Bristol Myers Squibb. In this role, he contributes his extensive expertise in quality oversight, product development, and technology transfer for advanced therapeutic products.
Education and Expertise
Donald Rodrick has a strong academic background in the field of molecular biology. He obtained a Master's degree in Cell/Cellular and Molecular Biology from Fairleigh Dickinson University, where he studied from 2001 to 2003. Prior to this, he earned a Master's degree in Medical Molecular Biology from the University of Westminster, completing his studies in 2000. His areas of expertise include quality oversight, analytical method development, risk management, and equipment validation.
Background
Before joining Bristol Myers Squibb, Donald Rodrick worked for The Janssen Pharmaceutical Companies of Johnson & Johnson. He served as a Staff Quality Engineer from 2007 to 2019, gaining invaluable experience in quality engineering and process qualification. During his tenure at Janssen, he specialized in quality oversight for product development, analytical method development, and process validation.
Achievements
Donald Rodrick has significant experience in quality management, specifically in the areas of product development and technology transfer for novel cell and immunotherapy products. His proficiency extends to analytical method development, qualification, and transfer. He is also well-versed in equipment validation, nonconformance/corrective and preventive actions (NC/CAPA), issue investigation, and change management.